TRPV1 inhibition attenuates IL-13 mediated asthma features in mice by reducing airway epithelial injury
Authors:
- Younus Ahmad BhatYBYounus Ahmad Bhat
- Lipsa PandaLPLipsa Panda
- Ulaganathan MabalirajanUMUlaganathan Mabalirajan
- 1 March 2013
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 15 (3) , 597-605
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research (CSIR), Government of India (NWP0033, MLP5502)
This publication has 45 references indexed in Scilit:
- Lebrikizumab Treatment in Adults with AsthmaNew England Journal of Medicine, 2011
- TRPV1 receptors in sensitisation of cough and pain reflexesPulmonary Pharmacology & Therapeutics, 2009
- TRPV1 Antagonists as Potential Antitussive AgentsLung, 2007
- The Asthma EpidemicNew England Journal of Medicine, 2006
- Cytokines, allergy, and asthmaCurrent Opinion in Allergy and Clinical Immunology, 2005
- Increased Expression of Transient Receptor Potential Vanilloid-1 in Airway Nerves of Chronic CoughAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Effect of the Airway Epithelium on the Contraction of Rat Isolated Trachea under Conditions of Low TemperatureRespiration, 2000
- Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity.Environmental Health Perspectives, 1995
- Neurogenic inflammation and sensitivity to environmental chemicals.Environmental Health Perspectives, 1993
- The Site of the Defect in AsthmaChest, 1987